Back

Advent International seeks more Australia, New Zealand healthcare deals after $715 million acquisition

Verifying
  • Advent International agreed to acquire a controlling stake in New Zealand Clinical Research.
  • The transaction valued NZCR at about $715 million, with financial terms undisclosed.
  • Advent’s Australia office head said the firm is pursuing further regional healthcare opportunities.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.